{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:19:07Z","timestamp":1726759147711},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T00:00:00Z","timestamp":1263168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T00:00:00Z","timestamp":1263168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/bmt.2009.341","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T11:53:59Z","timestamp":1263210839000},"page":"1309-1315","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation"],"prefix":"10.1038","volume":"45","author":[{"given":"U","family":"Denz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ihorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"W\u00e4sch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Finke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,11]]},"reference":[{"key":"BFbmt2009341_CR1","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa074306","volume":"358","author":"RF Schlenk","year":"2008","unstructured":"Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909\u20131918.","journal-title":"N Engl J Med"},{"key":"BFbmt2009341_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B Lowenberg","year":"1999","unstructured":"Lowenberg B, Downing JR, Burnett A . Acute myeloid leukemia. N Engl J Med 1999; 341: 1051\u20131062.","journal-title":"N Engl J Med"},{"key":"BFbmt2009341_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.bmt.1702519","volume":"26","author":"J Sierra","year":"2000","unstructured":"Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 2000; 26: 397\u2013404.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR4","first-page":"2931","volume":"90","author":"A Ferrant","year":"1997","unstructured":"Ferrant A, Labopin M, Frassoni F, Prentice HG, Cahn JY, Blaise D et al. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood 1997; 90: 2931\u20132938.","journal-title":"Blood"},{"key":"BFbmt2009341_CR5","first-page":"203","volume":"16","author":"RP Gale","year":"1995","unstructured":"Gale RP, Horowitz MM, Weiner RS, Ash RC, Atkinson K, Babu R et al. Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 1995; 16: 203\u2013208.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1046\/j.1365-2141.2002.03532.x","volume":"117","author":"HT Greinix","year":"2002","unstructured":"Greinix HT, Nachbaur D, Krieger O, Eibl M, Knobl P, Kalhs P et al. Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry. Br J Haematol 2002; 117: 914\u2013923.","journal-title":"Br J Haematol"},{"key":"BFbmt2009341_CR7","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325\u20134336.","journal-title":"Blood"},{"key":"BFbmt2009341_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/sj.leu.2402142","volume":"15","author":"G Visani","year":"2001","unstructured":"Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M et al. The prognostic value of cytogenetics is reinforced by the kind of induction\/consolidation therapy in influencing the outcome of acute myeloid leukemia\u2014analysis of 848 patients. Leukemia 2001; 15: 903\u2013909.","journal-title":"Leukemia"},{"key":"BFbmt2009341_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/sj.bmt.1700823","volume":"19","author":"H Bertz","year":"1997","unstructured":"Bertz H, Potthoff K, Mertelsmann R, Finke J . Busulfan\/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity. Bone Marrow Transplant 1997; 19: 1169\u20131173.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR10","first-page":"737","volume":"16","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Chan KW, Champlin RE, Culbert SJ, Petropoulos D, Ippoliti C et al. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients. Bone Marrow Transplant 1995; 16: 737\u2013741.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","volume":"57","author":"KM Sullivan","year":"1981","unstructured":"Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267\u2013276.","journal-title":"Blood"},{"key":"BFbmt2009341_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1053\/bbmt.2002.v8.abbmt080656","volume":"8","author":"A Bacigalupo","year":"2002","unstructured":"Bacigalupo A, Lamparelli T, Gualandi F, Bregante S, Raiola AM, Di Grazia C et al. Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants. Biol Blood Marrow Transplant 2002; 8: 656\u2013661.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009341_CR13","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V95.7.2219","volume":"95","author":"PB McGlave","year":"2000","unstructured":"McGlave PB, Shu XO, Wen W, Anasetti C, Nademanee A, Champlin R et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years\u2019 experience of the national marrow donor program. Blood 2000; 95: 2219\u20132225.","journal-title":"Blood"},{"key":"BFbmt2009341_CR14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V86.4.1606.bloodjournal8641606","volume":"86","author":"EW Petersdorf","year":"1995","unstructured":"Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606\u20131613.","journal-title":"Blood"},{"key":"BFbmt2009341_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1200\/JCO.2003.03.129","volume":"21","author":"J Finke","year":"2003","unstructured":"Finke J, Schmoor C, Lang H, Potthoff K, Bertz H . Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. J Clin Oncol 2003; 21: 506\u2013513.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009341_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bmt.1704758","volume":"35","author":"A Bacigalupo","year":"2005","unstructured":"Bacigalupo A . Antilymphocyte\/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects. Bone Marrow Transplant 2005; 35: 225\u2013231.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","volume":"10","author":"J Finke","year":"2009","unstructured":"Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009; 10: 855\u2013864.","journal-title":"Lancet Oncol"},{"key":"BFbmt2009341_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood-2006-10-043299","volume":"110","author":"MS Tallman","year":"2007","unstructured":"Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM et al. Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood 2007; 110: 409\u2013417.","journal-title":"Blood"},{"key":"BFbmt2009341_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbmt.2005.10.019","volume":"12","author":"G Cook","year":"2006","unstructured":"Cook G, Clark RE, Crawley C, Mackinnon S, Russell N, Thomson K et al. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. Biol Blood Marrow Transplant 2006; 12: 293\u2013300.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009341_CR20","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","volume":"24","author":"I Yakoub-Agha","year":"2006","unstructured":"Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10\/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006; 24: 5695\u20135702.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009341_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.bmt.1703373","volume":"29","author":"S Singhal","year":"2002","unstructured":"Singhal S, Powles R, Henslee-Downey PJ, Chiang KY, Treleaven J, Godder K et al. Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplant 2002; 29: 291\u2013295.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bbmt.2003.08.004","volume":"9","author":"HC Fung","year":"2003","unstructured":"Fung HC, Stein A, Slovak M, O\u2019Donnell MR, Snyder DS, Cohen S et al. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant 2003; 9: 766\u2013771.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009341_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.bbmt.2006.06.003","volume":"12","author":"EP Alyea","year":"2006","unstructured":"Alyea EP, Kim HT, Ho V, Cutler C, DeAngelo DJ, Stone R et al. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2006; 12: 1047\u20131055.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009341_CR24","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1182\/blood-2006-06-025627","volume":"109","author":"JJ Cornelissen","year":"2007","unstructured":"Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM et al. Results of a HOVON\/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood 2007; 109: 3658\u20133666.","journal-title":"Blood"},{"key":"BFbmt2009341_CR25","first-page":"1380","volume":"90","author":"JH Lee","year":"2005","unstructured":"Lee JH, Choi SJ, Seol M, Lee YS, Ryu SG, Park CJ et al. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia. Haematologica 2005; 90: 1380\u20131388.","journal-title":"Haematologica"},{"key":"BFbmt2009341_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","volume":"100","author":"HJ Deeg","year":"2002","unstructured":"Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA et al. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 2002; 100: 1201\u20131207.","journal-title":"Blood"},{"key":"BFbmt2009341_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.bmt.1702199","volume":"25","author":"F Frassoni","year":"2000","unstructured":"Frassoni F . Randomised studies in acute myeloid leukaemia: the double truth. Bone Marrow Transplant 2000; 25: 471\u2013473.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S1083-8791(00)70031-0","volume":"6","author":"DI Marks","year":"2000","unstructured":"Marks DI, Bird JM, Vettenranta K, Hunt L, Green A, Cornish JM et al. T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia. Biol Blood Marrow Transplant 2000; 6: 646\u2013653.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009341_CR29","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1182\/blood-2008-07-163212","volume":"113","author":"O Ringden","year":"2009","unstructured":"Ringden O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D et al. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 2009; 113: 3110\u20133118.","journal-title":"Blood"},{"key":"BFbmt2009341_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bmt.1705648","volume":"39","author":"C Heining","year":"2007","unstructured":"Heining C, Spyridonidis A, Bernhardt E, Schulte-Monting J, Behringer D, Grullich C et al. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplant 2007; 39: 613\u2013622.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009341_CR31","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1200\/JCO.2007.15.5184","volume":"26","author":"J Schetelig","year":"2008","unstructured":"Schetelig J, Bornhauser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J Clin Oncol 2008; 26: 5183\u20135191.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009341","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:30:13Z","timestamp":1648038613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,11]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFbmt2009341"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.341","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,11]]},"assertion":[{"value":"10 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}